Drugging the undruggable: Development of novel technologies to selectively regulate the expression of targets driving cancer and other diseases

Blancafort, Pilar (Chief Investigator)

School of Human Sciences

Project Details

Status	Finished
Effective start/end date	1/01/13 → 31/12/18

Funding

Australian Research Council: AUD188,830.00
Australian Research Council: AUD188,830.00
Australian Research Council: AUD188,830.00
Australian Research Council: AUD188,830.00

Access Project

http://purl.org/au-research/grants/arc/FT130101767

5 Article
1 Review article

Rab gtpases: Emerging oncogenes and tumor suppressive regulators for the editing of survival pathways in cancer
Krishnan, P. D. G., Golden, E., Woodward, E. A., Pavlos, N. J. & Blancafort, P., Feb 2020, In : Cancers. 12, 2, 259.
Research output: Contribution to journal › Review article

Open Access
10 Citations (Scopus)
Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
Moses, C., Nugent, F., Waryah, C. B., Garcia-Bloj, B., Harvey, A. R. & Blancafort, P., 1 Mar 2019, In : Molecular Therapy - Nucleic Acids. 14, p. 287-300 14 p.
Research output: Contribution to journal › Article

Open Access
16 Citations (Scopus)
Triple-hit therapeutic approach for triple negative breast cancers using docetaxel nanoparticles, EN1-iPeps and RGD peptides
Sorolla, A., Wang, E., Clemons, T. D., Evans, C. W., Plani-Lam, J. HC., Golden, E., Dessauvagie, B., Redfern, A. D., Swaminathan-Iyer, K. & Blancafort, P., 1 Aug 2019, In : Nanomedicine: Nanotechnology, Biology, and Medicine. 20, 102003.
Research output: Contribution to journal › Article

Open Access
13 Citations (Scopus)